You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Bintrafusp alfa (proposed INN)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

NSCLC Trial in Belgium, France, United States (Cisplatin, Carboplatin, Pemetrexed)

Completed
  • Carcinoma, Non-Small-Cell Lung
  • Fountain Valley, California
  • +18 more
Aug 10, 2022

NSCLC Trial in Worldwide (M7824, Placebo, Durvalumab)

Active, not recruiting
  • Non-small Cell Lung Cancer
  • Orange, California
  • +103 more
Nov 24, 2022

Resectable Lung Non-Small Cell Carcinoma, Stage I Lung Cancer AJCC v8, Stage IA1 Lung Cancer AJCC v8 Trial in Houston

Terminated
Has Results
  • Resectable Lung Non-Small Cell Carcinoma
  • +10 more
  • Bintrafusp Alfa
  • Therapeutic Conventional Surgery
  • Houston, Texas
    M D Anderson Cancer Center
Jul 27, 2022

Cervical Cancer Trial in Japan, Spain, United States (M7824, Carboplatin, Paclitaxel)

Completed
  • Cervical Cancer
  • Stanford, California
  • +12 more
Jan 27, 2023

Anatomic Stage IV Breast Cancer AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8, Hematopoietic and Lymphoid Cell Tumor

Recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +13 more
  • Bintrafusp Alfa
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Jul 14, 2022

Locally Advanced Intrahepatic Cholangiocarcinoma, Metastatic Intrahepatic Cholangiocarcinoma, Stage III Intrahepatic

Recruiting
  • Locally Advanced Intrahepatic Cholangiocarcinoma
  • +5 more
  • Bintrafusp Alfa
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 18, 2022

Anatomic Stage IV Breast Cancer AJCC v8, Hormone Receptor Positive Breast Adenocarcinoma, Metastatic Breast Carcinoma Trial in

Withdrawn
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +4 more
  • Bintrafusp Alfa
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Sep 2, 2022

Biliary Tract Cancer, Cholangiocarcinoma Trial in Aachen, Frankfurt (Bintrafusp alfa)

Terminated
  • Biliary Tract Cancer
  • Cholangiocarcinoma
  • Bintrafusp alfa
  • Aachen, Germany
  • +1 more
May 17, 2022

Ovarian Cancer Trial in Pittsburgh (Carboplatin AUC 5 and paclitaxel, Bintrafusp alfa (M7824))

Not yet recruiting
  • Ovarian Cancer
  • Carboplatin AUC 5 and paclitaxel
  • Bintrafusp alfa (M7824)
  • Pittsburgh, Pennsylvania
    University of Pittsburgh Medical Center
Jul 12, 2022

Lung Cancer, Cancer Trial in Rockland, Darmstadt, Madrid (Bintrafusp alfa)

Recruiting
  • Lung Cancer
  • Cancer
  • Bintrafusp alfa
  • Rockland, Massachusetts
  • +2 more
Dec 22, 2021

Uterine Cervical Tumors Trial in Worldwide (Bintrafusp alfa)

Active, not recruiting
  • Uterine Cervical Neoplasms
  • Bintrafusp alfa
  • Fayetteville, Arkansas
  • +72 more
Apr 7, 2022

Advanced Lung Non-Small Cell Carcinoma, Stage III Lung Cancer AJCC v8, Stage IIIA Lung Cancer AJCC v8 Trial in Scottsdale,

Active, not recruiting
  • Advanced Lung Non-Small Cell Carcinoma
  • +7 more
  • Scottsdale, Arizona
  • +2 more
Nov 3, 2021

Mesothelioma; Lung Trial in Spain (Bintrafusp alfa)

Recruiting
  • Mesothelioma; Lung
  • Bintrafusp alfa
  • Badalona, Barcelona, Spain
  • +14 more
Jun 1, 2022

Locally Advanced Lung Non-Squamous Non-Small Cell Carcinoma, Metastatic Lung Non-Squamous Non-Small Cell Carcinoma, Stage III

Terminated
  • Locally Advanced Lung Non-Squamous Non-Small Cell Carcinoma
  • +9 more
  • Bintrafusp Alfa
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Mar 4, 2022

Biliary Tract Cancer, Cholangiocarcinoma, Gallbladder Cancer Trial in Worldwide (M7824)

Completed
Has Results
  • Biliary Tract Cancer
  • +2 more
  • Scottsdale, Arizona
  • +32 more
Oct 21, 2022

Recurrent Head and Neck Squamous Cell Carcinoma, Second Primary Squamous Cell Carcinoma of the Head and Neck Trial in Houston

Recruiting
  • Recurrent Head and Neck Squamous Cell Carcinoma
  • Second Primary Squamous Cell Carcinoma of the Head and Neck
  • Bintrafusp Alfa
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Nov 17, 2021

Advanced Soft-tissue Sarcoma, Metastatic Soft-tissue Sarcoma Trial in France (Bintrafusp alfa, Doxorubicin)

Recruiting
  • Advanced Soft-tissue Sarcoma
  • Metastatic Soft-tissue Sarcoma
  • Bordeaux, France
  • +7 more
Dec 6, 2021

Squamous Cell Carcinoma of Head and Neck Trial in France (bintrafusp alfa)

Terminated
  • Squamous Cell Carcinoma of Head and Neck
  • bintrafusp alfa
  • Bordeaux, France
  • +7 more
Mar 28, 2022

Transitional Cell Carcinoma, Bladder Cancer Trial (Bintrafusp alfa)

Not yet recruiting
  • Transitional Cell Carcinoma
  • Bladder Cancer
  • Bintrafusp alfa
  • (no location specified)
May 6, 2021

Olfactory Neuroblastoma, Esthesioneuroblastoma, Tumor of the Nasal Cavity Trial run by the NCI (Bintrafusp alfa / M7824)

Recruiting
  • Olfactory Neuroblastoma
  • +2 more
  • Bintrafusp alfa / M7824
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jul 6, 2022

Study of the Use of the Drug Ingaron in Patients With COVID-19

Completed
  • COVID-19 Respiratory Infection
  • Viral Pneumonia
  • Interferon Gamma
  • Moscow, Russian Federation
    City Clinical Hospital named after M.E. Zhadkevich Moscow City H
May 23, 2022

Cancer, Solid Tumor, Metastatic Checkpoint Refractory HPV Associated Malignancies Trial run by the National Cancer Institute

Recruiting
  • Cancer
  • +3 more
  • Bintrafusp Alfa
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 11, 2022

COVID-19 Infection Trial in Washington, Philadelphia, Charleston (Zavegepant (BHV-3500), Placebo)

Terminated
  • COVID-19 Infection
  • Zavegepant (BHV-3500)
  • Placebo
  • Washington, District of Columbia
  • +2 more
Dec 16, 2022

Metastatic Solid Tumors Trial in Canada, United States (M6223, Bintrafusp alfa)

Recruiting
  • Metastatic Solid Tumors
  • Nashville, Tennessee
  • +3 more
Oct 14, 2021

Metastatic Cancer, Solid Tumors Trial run by the NCI (SX-682, M7824, MVA-BN-CV301)

Active, not recruiting
  • Metastatic Cancer
  • Solid Tumors
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jul 11, 2022